Author
Listed:
- Huai-Qiang Ju
(Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
The University of Texas MD Anderson Cancer Center)
- Haoqiang Ying
(The University of Texas MD Anderson Cancer Center)
- Tian Tian
(Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine)
- Jianhua Ling
(The University of Texas MD Anderson Cancer Center)
- Jie Fu
(The University of Texas MD Anderson Cancer Center)
- Yu Lu
(The University of Texas MD Anderson Cancer Center)
- Min Wu
(The University of Texas MD Anderson Cancer Center)
- Lifeng Yang
(Laboratory for Systems Biology of Human Diseases, Rice University)
- Abhinav Achreja
(Laboratory for Systems Biology of Human Diseases, Rice University)
- Gang Chen
(The University of Texas MD Anderson Cancer Center)
- Zhuonan Zhuang
(The University of Texas MD Anderson Cancer Center)
- Huamin Wang
(The University of Texas MD Anderson Cancer Center)
- Deepak Nagrath
(Laboratory for Systems Biology of Human Diseases, Rice University)
- Jun Yao
(The University of Texas MD Anderson Cancer Center)
- Mien-Chie Hung
(The University of Texas MD Anderson Cancer Center
The University of Texas Graduate School of Biomedical Sciences)
- Ronald A. DePinho
(The University of Texas Graduate School of Biomedical Sciences
The University of Texas MD Anderson Cancer Center)
- Peng Huang
(Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
The University of Texas MD Anderson Cancer Center
The University of Texas Graduate School of Biomedical Sciences)
- Rui-Hua Xu
(Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine)
- Paul J. Chiao
(The University of Texas MD Anderson Cancer Center
The University of Texas Graduate School of Biomedical Sciences)
Abstract
Kras activation and p16 inactivation are required to develop pancreatic ductal adenocarcinoma (PDAC). However, the biochemical mechanisms underlying these double alterations remain unclear. Here we discover that NAD(P)H oxidase 4 (NOX4), an enzyme known to catalyse the oxidation of NAD(P)H, is upregulated when p16 is inactivated by looking at gene expression profiling studies. Activation of NOX4 requires catalytic subunit p22phox, which is upregulated following Kras activation. Both alterations are also detectable in PDAC cell lines and patient specimens. Furthermore, we show that elevated NOX4 activity accelerates oxidation of NADH and supports increased glycolysis by generating NAD+, a substrate for GAPDH-mediated glycolytic reaction, promoting PDAC cell growth. Mechanistically, NOX4 was induced through p16-Rb-regulated E2F and p22phox was induced by KrasG12V-activated NF-κB. In conclusion, we provide a biochemical explanation for the cooperation between p16 inactivation and Kras activation in PDAC development and suggest that NOX4 is a potential therapeutic target for PDAC.
Suggested Citation
Huai-Qiang Ju & Haoqiang Ying & Tian Tian & Jianhua Ling & Jie Fu & Yu Lu & Min Wu & Lifeng Yang & Abhinav Achreja & Gang Chen & Zhuonan Zhuang & Huamin Wang & Deepak Nagrath & Jun Yao & Mien-Chie Hun, 2017.
"Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14437
DOI: 10.1038/ncomms14437
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14437. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.